Biochemist honoured for his research in the use of mass spectrometry in the diagnosis of brain neoplasms during surgery
David Calligaris is the winner of this year’s ABC Best Paper Award, presented by the Springer journal Analytical and Bioanalytical Chemistry. In a paper published in ABC, lead author Calligaris and his colleagues describe a novel system using mass spectrometry as an intraoperative tool. Their method opens new possibilities to detect additional tumour markers which are useful in diagnosing brain and breast tumours during surgery. The award, accompanied by 1,500 euros, was created by Springer to honour exceptional young scientists and to stimulate their research careers. The ABC Best Paper Award has been given since 2005.
Surgery remains the first line of treatment for brain tumours. To guide surgeons in maximizing the removal of tumor and minimizing the removal of functional healthy tissue, there is an increasing need to develop new techniques to do near real-time diagnosis of surgical samples. Mass spectrometry has the ability to characterize biological tissues with high sensitivity and specificity and can complement all the techniques already used in the intraoperative context, for example ultrasound or MRI. Calligaris and his team demonstrate that the droplet-based liquid microjunction surface-sampling-HPLC–ESI-MS–MS system has the capacity to differentiate normal tumour tissue in a shorter timeframe than traditional histopathology evaluation.
David Calligaris received his Ph.D. in human pathology with specialization in oncology at Aix-Marseille University in France. As a research fellow at Brigham and Women’s Hospital/Harvard Medical School, USA, his current focus is the study of brain neoplasms using mass spectrometry-based approaches. Calligaris also performs drug development research using mass spectrometry-based pharmacokinetic/pharmacodynamic methods.
Alfredo Sanz-Medel, Editor of ABC, said: “The winning ABC article this year is an excellent example of extending the applicability of precise and sophisticated sampling instrumentation – Single Droplet Liquid Extraction-Surface Sampling, coupled to HPLC separation and MS detection – to spatially resolve and detect bigger molecules, for example proteins, in human tissue sections. The new hybrid analytical tool has been successfully validated versus more conventional imaging approaches for the rapid monitoring of two key protein (cancer biomarkers) levels in the human pituitary gland. As demonstrated in the paper, this liquid alternative to solid direct ‘ambient-desorption’ holds considerable potential to become a competitive tool for surgical decision making – in other words, for cancer-affected tissue detection from tissue biopsy samples, directly in the operating environment."
Analytical and Bioanalytical Chemistry’s mission is the rapid publication of excellent and high-impact research articles on fundamental and applied topics of analytical and bioanalyti¬cal science. Its scope is broad, encompassing the entire range of analytical and bioanalytical research and encouraging multidisciplinary solutions to problems in this field. ABC counts among the leading journals in its field and is partly owned by eight prestigious chemical societies.
Further Information
About the journal Analytical and Bioanalytical Chemistry
www.springer.com/journal/00216
The article “Profiling of adrenocorticotropic hormone and arginine vasopressin in human pituitary gland and tumor thin tissue sections using droplet-based liquid-microjunction surface-sampling-HPLC–ESI-MS–MS” by Vilmos Kertesz, David Calligaris, Daniel R. Feldman, Armen Changelian, Edward R. Laws, Sandro Santagata, Nathalie Y. R. Agar, and Gary J. Van Berkel is freely available online at http://link.springer.com/article/10.1007/s00216-015-8803-2 or can be requested as a PDF.
Contact
Joan Robinson | Springer Nature | Communications
tel +49 6221 487 8130 |
Springer is part of Springer Nature, a leading global research, educational and professional publisher, home to an array of respected and trusted brands providing quality content through a range of innovative products and services. Springer Nature is the world’s largest academic book publisher, publisher of the world’s highest impact journals and a pioneer in the field of open research. The company numbers almost 13,000 staff in over 50 countries and has a turnover of approximately €1.5 billion. Springer Nature was formed in 2015 through the merger of Nature Publishing Group, Palgrave Macmillan, Macmillan Education and Springer Science+Business Media. Find out more: (www.springernature.com)
Springer Verlag, Heidelberg | New York
11 February 2016